Advertisement

Pflügers Archiv

, Volume 446, Issue 4, pp 437–446 | Cite as

Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes

  • W. BriestEmail author
  • B. Raßler
  • A. Deten
  • M. Leicht
  • R. Morwinski
  • D. Neichel
  • G. Wallukat
  • T. Ziegelhöffer
  • H.-G. Zimmer
Cell and Molecular Physiology

Abstract

Continuous i.v. infusion of norepinephrine in rats has been shown to induce early interleukin (IL)-6 mRNA expression in the left ventricle (LV) which was followed by hypertrophy and fibrosis. In this study, two approaches were used. In the first, NE (0.1 mg/kg per hour) was infused i.v. in rats for several time periods, and freshly obtained ventricular myocardium was dissociated into myocyte (MC) and non-myocyte (NMC) fractions. Second, isolated adult MCs and fibroblasts were treated with NE (10 μM). NE infusion (4 h, in vivo) caused an 11-fold increase in IL-6 mRNA in both cell populations. In vitro treatment of isolated adult MCs for 2 h and of fibroblasts for 1 h with NE induced a 3.5- and 23-fold maximum increase, respectively, in IL-6 mRNA. After in vivo NE treatment, the expression of the mRNA of the transcriptional factor of IL-6, C/EBP-β, was elevated earlier (after 45 min of NE infusion) than IL-6 mRNA (after 4 h) and was seen in MCs and NMCs. The mRNAs of both receptors of IL-6, the soluble IL6R and gp130, were increased subsequently to IL-6 mRNA. Gp130 was elevated after 24 h and, like IL6R, predominantly in NMCs. In contrast, the IL6R protein and the downstream regulator STAT3 were increased only in MCs after 24 h of NE infusion. The mRNA of C/EBP-δ, which is regulated by STAT3, was elevated only in myocytes.

Keywords

Cell culture Cytokines IL-6 mRNA In vivo rat heart Norepinephrine Protein phosphorylation RNase protection assay Signal transduction 

Notes

Acknowledgements

This work was supported by the Deutsche Forschungsgemeinschaft (ZI 199/10-3, ZI 199/10-4), by a grant from the Medical Faculty of the University of Leipzig (formel.1-10) and by a grant of BMBF (NBL-3-Förderung; Kennzeichen 01ZZ0106). The excellent technical assistance of Grit Marx is gratefully appreciated.

References

  1. 1.
    Zierhut W, Zimmer H-G (1989) Significance of myocardial alpha- and beta-adrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 65:1417–1425PubMedGoogle Scholar
  2. 2.
    Barth W, Deten A, Bauer M, Reinohs M, Leicht M, Zimmer H-G (2000) Differential remodeling of the left and right heart after norepinephrine treatment in rats: studies on cytokines and collagen. J Mol Cell Cardiol 32:273–284PubMedGoogle Scholar
  3. 3.
    Bürger A, Benicke M, Deten A, Zimmer H-G (2001) Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am J Physiol 281:H14–H21Google Scholar
  4. 4.
    Wollert KC, Drexler H (2001) The role of interleukin-6 in the failing heart. Heart Fail Rev 6:95–103CrossRefPubMedGoogle Scholar
  5. 5.
    Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9:1897–1906PubMedGoogle Scholar
  6. 6.
    Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 90:10193–10197PubMedGoogle Scholar
  7. 7.
    Libermann TA, Baltimore D (1990) Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 10:2327–2334PubMedGoogle Scholar
  8. 8.
    Dendorfer U, Oettgen P, Libermann TA (1994) Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol Cell Biol 14:4443–4454PubMedGoogle Scholar
  9. 9.
    Sehgal PB (1992) Regulation of IL6 gene expression. Res Immunol 143:724–734PubMedGoogle Scholar
  10. 10.
    Wedel A, Ziegler-Heitbrock HW (1995) The C/EBP family of transcription factors. Immunobiology 193:171–185PubMedGoogle Scholar
  11. 11.
    Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, Kishimoto T (1998) Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98:346–352PubMedGoogle Scholar
  12. 12.
    Lutticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga T, et al (1994) Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science 263:89–92PubMedGoogle Scholar
  13. 13.
    Leicht M, Greipel N, Zimmer H-G (2000) Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. Cardiovasc Res 48:274–284PubMedGoogle Scholar
  14. 14.
    Nees S, Dendorfer A (1990) Regulation of the myocardial blood supply by adenosine and adenine nucleotides: consequences of newly detected barrier functions of the coronary endothelium. In: Wilson G, Davis SS, Illum L (eds) Pharmaceutical application of cell and tissue culture. Plenum Press, New York, pp 72–79Google Scholar
  15. 15.
    Volz A, Piper HM, Siegmund B, Schwartz P (1991) Longevity of adult ventricular rat heart muscle cells in serum-free primary culture. J Mol Cell Cardiol 23:161–173PubMedGoogle Scholar
  16. 16.
    Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 162:156–159PubMedGoogle Scholar
  17. 17.
    Deten A, Volz HC, Briest W, Zimmer H-G (2002) Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55:329–340PubMedGoogle Scholar
  18. 18.
    Deten A, Hölzl A, Leicht M, Barth W, Zimmer H-G (2001) Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 33:1191–1207PubMedGoogle Scholar
  19. 19.
    Piechaczyk M, Blanchard JM, Marty L, Dani C, Panabieres F, El Sabouty S, Fort P, Jeanteur P (1984) Post-transcriptional regulation of glyceraldehyde-3-phosphate dehydrogenase gene expression in rat tissues. Nucleic Acids Res 12:6951–6963PubMedGoogle Scholar
  20. 20.
    Briest W, Hölzl A, Raßler B, Deten A, Leicht M, Baba HA, Zimmer H-G (2001) Cardiac remodeling after long-term norepinephrine treatment in rats. Cardiovasc Res 52:265–273CrossRefPubMedGoogle Scholar
  21. 21.
    Kondo K, Okada T, Matsui T, Kato S, Date K, Yoshihara M, Nagata Y, Takagi H, Yoneda M, Sugie I (2001) Establishment and characterization of a human B cell line from the lung tissue of a patient with scleroderma; extraordinary high level of IL-6 secretion by stimulated fibroblasts. Cytokine 13:220–226CrossRefPubMedGoogle Scholar
  22. 22.
    Xue H, McCauley RL, Zhang W (2000) Elevated interleukin-6 expression in keloid fibroblasts. J Surg Res 89:74–77CrossRefPubMedGoogle Scholar
  23. 23.
    Deten A, Volz HC, Briest W, Zimmer H-G (2003) Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats. Mol Cell Biochem 242:47–55CrossRefPubMedGoogle Scholar
  24. 24.
    Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S (1998) Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98:149–156PubMedGoogle Scholar
  25. 25.
    Yue P, Massie BM, Simpson PC, Long CS (1998) Cytokine expression increases in non-myocytes from rats with postinfarction heart failure. Am J Physiol 275:H250–H258PubMedGoogle Scholar
  26. 26.
    Leicht M, Briest W, Zimmer H-G (2003) Regulation of norepinephrine-induced proliferation in cardiac fibroblasts by interleukin-6 and p42/p44 mitogen activated protein kinase. Mol Cell Biochem 243:65–72Google Scholar
  27. 27.
    Ancey C, Corbi P, Froger J, Delwail A, Wijdenes J, Gascan H, Potreau D, Lecron JC (2002) Secretion of IL-6, IL-11 and lif by human cardiomyocytes in primary culture. Cytokine 18:199–205CrossRefPubMedGoogle Scholar
  28. 28.
    Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR (1996) Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 271:9535–9545CrossRefPubMedGoogle Scholar
  29. 29.
    Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 6:583–588CrossRefPubMedGoogle Scholar
  30. 30.
    Hirota H, Yoshida K, Kishimoto T, Taga T (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92:4862–4866PubMedGoogle Scholar
  31. 31.
    Alam T, An MR, Papaconstantinou J (1992) Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem 267:5021–5024PubMedGoogle Scholar
  32. 32.
    Cantwell CA, Sterneck E, Johnson PF (1998) Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1. Mol Cell Biol 18:2108–2117Google Scholar
  33. 33.
    Yamada T, Tobita K, Osada S, Nishihara T, Imagawa M (1997) CCAAT/enhancer-binding protein delta gene expression is mediated by APRF/STAT3. J Biochem (Tokyo) 121:731–738Google Scholar
  34. 34.
    Fukuoka T, Kitami Y, Okura T, Hiwada K (1999) Transcriptional regulation of the platelet-derived growth factor alpha receptor gene via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells. J Biol Chem 274:25576–25582CrossRefPubMedGoogle Scholar
  35. 35.
    Yang ZH, Kitami Y, Takata Y, Okura T, Hiwada K (2001) Targeted overexpression of CCAAT/enhancer-binding protein-delta evokes enhanced gene transcription of platelet-derived growth factor alpha- receptor in vascular smooth muscle cells. Circ Res 89:503–508PubMedGoogle Scholar
  36. 36.
    Hutt JA, O'Rourke JP, DeWille J (2000) Signal transducer and activator of transcription 3 activates CCAAT enhancer-binding protein delta gene transcription in G0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland. J Biol Chem 275:29123–29131CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag  2003

Authors and Affiliations

  • W. Briest
    • 1
    Email author
  • B. Raßler
    • 1
  • A. Deten
    • 1
  • M. Leicht
    • 1
  • R. Morwinski
    • 2
  • D. Neichel
    • 2
  • G. Wallukat
    • 2
  • T. Ziegelhöffer
    • 3
  • H.-G. Zimmer
    • 1
  1. 1.Carl-Ludwig-Institute of PhysiologyUniversity of Leipzig LeipzigGermany
  2. 2.Max-Delbrück-Center for Molecular MedicineBerlin-BuchGermany
  3. 3.Department of Experimental CardiologyMax-Planck-InstituteBad NauheimGermany

Personalised recommendations